Impact of pre‐analytical sample handling factors on plasma biomarkers of Alzheimer's disease - Kurz - Journal of Neurochemistry - Wiley Online Library
Blood Pressure Monitoring Devices Archives - DelveInsight
Roche, Eli Lilly team up on Alzheimer's blood test
Roche announces collaboration with Lilly to enhance early diagnosis of Alzheimer's disease
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS - ScienceDirect
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance | medRxiv
Roche, Lilly partner to boost early diagnosis of Alzheimer's disease
PDF) Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
The Power of Elecsys® in Alzheimer's disease
Roche bags USFDA Breakthrough Device Designation for Elecsys Amyloid Plasma Panel for early detection of Alzheimer's disease
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease - Palmqvist - Alzheimer's & Dementia - Wiley Online Library
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers | EMBO Molecular Medicine
US FDA approves Roche's two Elecsys CSF assays to detect Alzheimer's
Frontiers | Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS - ScienceDirect
Roche announces collaboration with Lilly to enhance early diagnosis of Alzheimer's disease
Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation | Alzheimer's Research & Therapy | Full Text
Bertrand Delsuc on Twitter: "$ROG $RHHBY to present biomarkers data & strategy (and CDx) in Alzheimer's at #AAIC22 https://t.co/VhTCqazFku" / Twitter
Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation | Alzheimer's Research & Therapy | Full Text
Roche's Alzheimer's Early Detection Test Earns Breakthrough Nod | Medical Product Outsourcing
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease | Nature Medicine
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques | Neurology
Elecsys® β-Amyloid(1-42) CSF II
Roche's Elecsys Amyloid Plasma Panel Granted FDA Breakthrough Device Designation to Enable a Timely Diagnosis of Alzheimer's Disease
FDA Grants Breakthrough Device Designation for Roche Alzheimer's Early-Detection Solution | Clinical Lab Products
Панель Elecsys Amyloid Plasma Panel компании Roche получила статус прорывного устройства FDA для своевременной диагностики болезни Альцгеймера - ТехМедЭКСПО
